According to the relevant provisions of the 'Environmental Impact Assessment Law of the People's Republic of China' and 'Measures for Public Participation in Environmental Impact Assessment' (Decree No. 4 of the Ministry of Ecology and Environment), the second information disclosure of the environmental impact assessment of the 'Vaccine Quality Research Center Project' is required , so that the public can understand the project situation, and at the same time understand the public's suggestions and opinions on the environmental protection of the project construction, and accept the supervision of the whole public.

The web link to the full text of the draft environmental impact report and the ways and means to consult the paper report

Web Link: EIA Report - Vaccine Quality Research Center.pdf

Ways and means of consulting the paper report: The public can go to the construction unit Beijing Kexing Biological Products Co., Ltd. to view the paper report

Scope of public opinion solicitation

Citizens, legal persons and other organizations within the scope of environmental impact assessment.

Web Links to Public Comment Forms

Web Link: Public Opinion Form for Environmental Impact Assessment of Construction Projects.pdf

Ways and means of submitting the public opinion form

About SINOVAC

Sinovac Biotech Ltd. (Sinovac Biotech Ltd., SINOVAC Kexing) is a leading biological high-tech enterprise in China. With the mission of 'providing vaccines for human elimination of diseases', it is committed to the research of human vaccines and related products, Development, production and sales, providing services for global disease prevention and control.

The vaccines developed by SINOVAC mainly include vaccines against common infectious diseases such as viral hepatitis, influenza, pneumonia, polio, chicken pox, and mumps, as well as against SARS, H5N1 avian influenza, H1N1 influenza, EV71 hand, foot and mouth disease, new Vaccines for new and sudden infectious diseases such as coronavirus infection.

The company's existing 4 vaccines have passed the pre-certification of the World Health Organization (inactivated hepatitis A vaccine, inactivated polio vaccine of Sabin strain, live attenuated varicella vaccine) or included in the emergency use list (inactivated vaccine of new coronavirus), the quality of the vaccine The management system has been recognized by international organizations and multinational drug regulatory authorities.

SINOVAC is constantly exploring opportunities in the international market, and has exported vaccines to dozens of countries and international organizations.

Contact:

Tel: +86-10-8289-0088

Fax: +86-10-6296-6910

Email: sinovac@sinovac.com

(C) 2023 Electronic News Publishing, source ENP Newswire